Biotinylated Human CD155, Fc,Avitag on SDS-PAGE under reducing (R) and non-reducing (NR) conditions. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 95%.
Immobilized Human TIGIT, Fc Tag at 2 ug/mL (100 uL/well) can bind Biotinylated Human CD155, Fc,Avitag with a linear range of 0.5-16 ng/mL.
Immobilized Human DNAM-1, Fc Tag at 2 ug/mL (100 uL/well) can bind Biotinylated Human CD155, Fc,Avitag with a linear range of 0.02-0.312 ug/mL.
Serial dilutions of TIGIT antibody antibody (1:2 serial dilutions, from 20 ug/mL to 0.0097 ug/mL) were added into Human TIGIT, His Tag: Biotinylated Human CD155, Fc,Avitag binding reactions. The assay was performed according to the above described protocol. Background was subtracted from data points before curve fitting.
FACS assay shows that Biotinylated Human CD155, Fc,Avitag can bind to 293T cell overexpressing human TIGIT. The concentration of CD155 is 1 ug/mL.
FACS analysis shows that the binding of Biotinylated Human CD155, Fc,Avitag to 293T overexpressing TIGIT was inhibited by increasing concentration of neutralizing Anti-Human TIGIT MAb. The concentration of CD155 used is 1 ug/mL. The IC50 is 0.201 ug/mL.